Nanoscope Therapeutics Press Releases
-
Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor
April 25, 2024 by Nanoscope Therapeutics
-
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
April 17, 2024 by Nanoscope Therapeutics
-
Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa
March 26, 2024 by Nanoscope Therapeutics
-
Nanoscope Therapeutics Announces Participation in Upcoming Conferences
February 21, 2024 by Nanoscope Therapeutics
Nanoscope Therapeutics In the News
- Pharmaphorum: Nanoscope preps filing for retinitis pigmentosa gene therapy
- Fierce Biotech: Nanoscope eyes market after gene therapy restores vision for patients with retinal disease
- Modern Retina : https://www.modernretina.com/view/mco-010-optogenetic-gene-therapy-for-severe-vision-loss-in-stargardt-disease
- The Healthcare Technology Report: The Top 25 Women Leaders in Biotechnology of 2023
- Eyewire.com : Nanoscope Therapeutics Wins ‘Best of Show’ Award at AAO Eyecelerator 2023